[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339091-105":59,"doc-detail-339091-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-significance-and-immunological-role-of-hprt1-in-human-cancers","Prognostic significance and immunological role of HPRT1 in human cancers","","Hypoxanthine phosphoribosyl transferase 1 (HPRT1), previously regarded as a housekeeping gene, is examined for its tumor prognostic value and immunological function across human cancers. Using multiomics datasets from TCGA and GEO, the study links HPRT1 with clinical parameters, survival outcomes, and tumor immunity, and identifies 16 HPRT1-targeting effective drugs via drug sensitivity screening. Immunohistochemistry across five tumor types confirms differential HPRT1 expression versus adjacent normal tissues (P \u003C 0.05). A ceRNA network is built for HNSC, and cellular experiments support HPRT1’s oncogenic effects on proliferation, migration, invasion, and apoptosis, including positive association with PD-1 expression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-significance-and-immunological-role-of-hprt1-in-human-cancers/339091/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-significance-and-immunological-role-of-hprt1-in-human-cancers/339091.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the primary focus of the study on HPRT1 in cancers?","Question",{"text":112,"@type":113},"The study evaluates how HPRT1 relates to clinical parameters, survival prognosis, and tumor immunity in human cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was HPRT1 expression validated across tumor types?",{"text":117,"@type":113},"Immunohistochemistry confirmed significant expression differences of HPRT1 between five tumor types and adjacent normal tissues, with P \u003C 0.05.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports HPRT1’s role in HNSC?",{"text":121,"@type":113},"Cytological experiments verified that HPRT1 promotes tumorigenic behaviors in HNSC, including effects on proliferation, migration, invasion, and apoptosis, and it correlates positively with PD-1 expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339091,1791085284,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","RESEARCH ARTICLE  \nPrognostic significance and immunological role of HPRT1 in human cancers  \nYiwen Lu 1, Ruixue Chen 1, Han Zhang 2, Xu Sun 1, Xiangjun Li 1, Mengyuan Yang 1, and Xudong Zhang 1 ∗  \nHypoxanthine phosphoribosyl transferase 1 (HPRT1), once considered a housekeeping gene, has been identified as playing an important role in several tumors. Its role in pan-cancer, however, has not been systematically studied. This study evaluates the relationship between HPRT1 and clinical parameters, survival prognosis, and tumor immunity based on multiomics data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases. Drug sensitivity analysis screened 16 effective drugs against HPRT1, exploring the interactions with chemicals and genes. The significance of HPRT1 in tumor immunotherapy has also been investigated. Immunohistochemistry confirmed significant differences in the expression of HPRT1 between five tumor types (colon adenocarcinoma [COAD], head–neck squamous cell carcinoma [HNSC], lung adenocarcinoma [LUAD], thyroid carcinoma [THCA], uterine corpus endometrial carcinoma [UCEC]), and adjacent normal tissues (P \u003C 0.05). HPRT1 competitive endogenous RNA (ceRNA) network was constructed in HNSC. Through cytological experiments, it was verified that HPRT1 plays a carcinogenic role in HNSC and is associated with tumor cell proliferation, migration, invasion, and apoptosis. In addition, there was a significant positive correlation between HPRT1 and programmed cell death-1 (PD-1) expression in HNSC (P \u003C 0.05). These findings suggest that HPRT1 may be a potential biomarker for predicting and treating cancer.  \nKeywords: Pan-cancer, hypoxanthine phosphoribosyl transferase 1 (HPRT1), immunity, cancer risk factors, prognosis.  \nIntroduction  \nHypoxanthine phosphoribosyl transferase 1 (HPRT1) was previously thought to be a housekeeping gene that encodes enzymes that can participate in the cell cycle by regulating the purine and inosine production, essential for cell growth [1] . HPRT1, asa salvage pathway enzyme, transfers phosphoribose from phosphoribosyl diphosphate to hypoxanthine and guanine bases, forming inosine monophosphate and guanine monophosphate, respectively. These compounds are subsequently converted into functional nucleotides for DNA synthesis and repair [2] .  \nThe expression level of HPRT1 is abnormally high in central nervous system tissues, four times higher than in other somatic tissues, although the reason for this elevated expression is unknown [3, 4] . It is worth noting that individuals with complete HPRT1 deﬁciency develop Lesch–Nyhan syndrome, while partial deﬁciency leads to gout-like symptoms unique to Kelly–Seegmiller syndrome [3, 5] . Patients with severe Lesch–Nyhan syndrome may suﬀer from motor dysfunction similar to severe cerebral palsy, intellectual disability, and self-harming behaviors [6] .  \nRecent studies have found HPRT1’s upregulation in various cancers and its involvement in tumor development. These cancers include invasive breast carcinoma (BRCA), head and neck squamous cell carcinoma (HNSC), lung adenocarcinoma  \n(LUAD), lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD), and uterine corpus endometrial carcinoma (UCEC) [7–11] . HPRT1 was expressed at higher levels in endometrial cancer than in normal tissue and was signiﬁcantly associated with cancer grade. It was also associated with overall survival (OS) and is sensitive to DNA topoisomerase I (Topo I) and mitogen-activated extracellular signal-regulated kinase (MEK) inhibitors [7] . Compared with normal controls, HPRT1 RNA levels in breast cancer tissues were signiﬁcantlyelevated, particularly in basal cells and triple-negative breast cancer, suggesting its involvement in cancer progression by positively regulating genes associated with cancer pathways [8] . HPRT1 levels were also signiﬁcantly upregulated in prostate cancer samples. HPRT1 levels are elevated in approximately 47% of patients co","cbCaiu4Wo8CWQ8JT","https://ap.wps.com/l/cbCaiu4Wo8CWQ8JT","pdf",17608533,"English","# Keywords\n# Introduction","[{\"question\":\"What is the primary focus of the study on HPRT1 in cancers?\",\"answer\":\"The study evaluates how HPRT1 relates to clinical parameters, survival prognosis, and tumor immunity in human cancers.\"},{\"question\":\"How was HPRT1 expression validated across tumor types?\",\"answer\":\"Immunohistochemistry confirmed significant expression differences of HPRT1 between five tumor types and adjacent normal tissues, with P \\u003c 0.05.\"},{\"question\":\"What experimental evidence supports HPRT1’s role in HNSC?\",\"answer\":\"Cytological experiments verified that HPRT1 promotes tumorigenic behaviors in HNSC, including effects on proliferation, migration, invasion, and apoptosis, and it correlates positively with PD-1 expression.\"}]","Prognostic significance and immunological role of HPRT1 in human cancers | PDF",1790027821,76,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bbfbcf6f426c4c57414c51fbd698bcd.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/677311bbddf6695b9d201522e4d4de2e.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ad822142e90644d4505c92e5223c7a2.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf001055daaea996aa767cc128b47bab.webp",980,1268]